Overview

A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke

Status:
RECRUITING
Trial end date:
2026-06-28
Target enrollment:
Participant gender:
Summary
The purpose of this interventional study is to determine whether neflamapimod can improve residual physical disability and/or cognitive dysfunction after Moderate to Severe Acute Ischaemic Stroke.
Phase:
PHASE2
Details
Lead Sponsor:
EIP Pharma Inc
Collaborator:
CervoMed, Inc